TherapeuticsMD TXMD
NASDAQ TXMD
$2.06 +0.03 (+1.49%)
At close: Aug 20, 2026 · 9:47 AM UTC

TherapeuticsMD (TXMD) Revenue (2011 - 2026)

TherapeuticsMD's (TXMD) quarterly Revenue came in at $724000.0 in Q1 2026, up 84.22% YoY from $393000.0 in Q1 2025, and down 18.92% on a QoQ basis from $893000.0 in Q4 2025.

TherapeuticsMD (TXMD) Revenue (2011 - 2026) Analysis & Trends

TherapeuticsMD (TXMD) has 16 years of Revenue data on file, last reported at $724000.0 in Q1 2026.

  • Quarterly Revenue rose 84.22% year-over-year to $724000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 82.13% YoY) and the FY2025 annual result came in at $3.0 million, up 71.61% from the prior year.
  • Revenue retreated to $724000.0 in Q1 2026, from $893000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $68.6 million in Q4 2022 to a low of $53000.0 in Q3 2023.
  • A 5-year average of $4.5 million and a median of $469000.0 in 2023 frame the typical range for Revenue.
  • Annual changes were most pronounced in 2023 — Revenue tumbled 99.32% — and 2024, when it soared 932.08%.
  • Tracing TXMD's Revenue over 5 years: stood at $68.6 million in 2022, then plunged by 99.32% to $469000.0 in 2023, then jumped by 42.22% to $667000.0 in 2024, then soared by 33.88% to $893000.0 in 2025, then slipped by 18.92% to $724000.0 in 2026.
  • The last three Revenue figures came in at $724000.0 (Q1 2026), $893000.0 (Q4 2025), and $784000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Haleon 43.71 Bn 42.75 Bn - -
2 Teva Pharmaceutical Industries 43.11 Bn 39.45 Bn 2.15 Bn 4.14 Bn
3 Zoetis 31.62 Bn 29.94 Bn 1.05 Bn 2.47 Bn
4 Takeda Pharmaceutical 28.72 Bn 22.92 Bn 5.10 Bn 7.65 Bn
5 United Therapeutics 22.33 Bn 19.67 Bn 683.80 Mn 783.30 Mn
6 Viatris 18.83 Bn 17.95 Bn 1.46 Bn 3.76 Bn
7 Neurocrine Biosciences 15.62 Bn 15.23 Bn 935.80 Mn 959.00 Mn
8 Elanco Animal Health 12.10 Bn 11.57 Bn 798.00 Mn 1.37 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 TherapeuticsMD 23.84 Mn 14.65 Mn - 869,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 869,000.00
Mar 31, 2026 724,000.00
Dec 31, 2025 893,000.00
Sep 30, 2025 784,000.00
Jun 30, 2025 952,000.00
Mar 31, 2025 393,000.00
Dec 31, 2024 667,000.00
Sep 30, 2024 547,000.00
Jun 30, 2024 234,000.00
Mar 31, 2024 313,000.00
Dec 31, 2023 469,000.00
Sep 30, 2023 53,000.00
Jun 30, 2023 437,000.00
Mar 31, 2023 416,000.00
Dec 31, 2022 68.57 Mn
Sep 30, 2022 354,000.00
Jun 30, 2022 348,000.00
Mar 31, 2022 695,000.00
Dec 31, 2021 18.68 Mn
Sep 30, 2021 25.41 Mn